The core activity of ASCHEM GmbH is the development, synthesis and marketing of various chemical building blocks for drug development and production, as well as the provision of services in the field of nanotechnology, including the development of nano-based drug formulations and targeted drug delivery systems.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Tailor-made syntheses, custom synthesis, FTE and FFS contracts, as well as consulting for research, drug substance development, and pharmaceutical applications.
Compounds
Small molecules, macromolecules, building blocks, reagents and functional products for drug discovery, the pharmaceutical industry and chemical research.
Specialty Chemical Reagents and Building Blocks
Specialty reagents, reaction building blocks and starting materials for APIs and reaction substrates, including functional groups such as amino-, azide- and alkynyl-containing compounds.
APIs and Intermediates
APIs, API intermediates, pharmaceutical active ingredients and related building blocks for drug development and the pharmaceutical industry.
Bioconjugates and Nanoparticles
Bioconjugates, nanoparticles and nanoscale materials for nanomedical applications, including nanocarrier-based drug formulation and targeted drug delivery.
Knowledge
No knowledge articles yet
Once Aschem GmbH has claimed this profile, we'll publish editorial articles and case studies here together.